Bone marrow stem cells-derived microvesicles protect against renal injury in the mouse remnant kidney model

Nephrology

Volumn 17, Issue 5, 2012, Pages 493-500

  He, Juan ^a   Wang, Yan ^a   Sun, Shu ^a   Yu, Meining ^a   Wang, Cuiyu ^a   Pei, Xiaohua ^a   Zhu, Bei ^a   Wu, Jianqing ^a   Zhao, Weihong ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

5 6 subtotal nephrectomy; kidney injury; mesenchymal stem cell; microvesicle

Indexed keywords

CREATININE; URIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HISTOPATHOLOGY; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY TUBULE DAMAGE; LYMPHOCYTIC INFILTRATION; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL MICROVESICLE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ANIMALS; ATROPHY; BIOLOGICAL MARKERS; BLOOD UREA NITROGEN; BONE MARROW TRANSPLANTATION; CELL-DERIVED MICROPARTICLES; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; CREATININE; CYTOPROTECTION; DISEASE MODELS, ANIMAL; FIBROSIS; KIDNEY; KIDNEY DISEASES; LYMPHOCYTES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, INBRED C57BL; NEPHRECTOMY; PROTEINURIA; TIME FACTORS; URIC ACID;

EID: 84862981326     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2012.01589.x     Document Type: Article

References (45)

1. Dezawa M,. Tissue repairing cells that exist among mesenchymal stem cells: their potential for cell-based therapy. Nihon Rinsho. 2011; 69 (12): 2128-35.
2. Srinivasan R, Balow JE, Sabnis S, et al,. Nephrotic syndrome: An under-recognised immune-mediated complication of non-myeloablative allogeneic haematopoietic cell transplantation. Br. J. Haematol. 2005; 131 (1): 74-9. (Pubitemid 43899711)
3. Humphreys BD, Bonventre JV,. Mesenchymal stem cells in acute kidney injury. Annu. Rev. Med. 2008; 59: 311-25. (Pubitemid 351287940)
4. Tschöpe C, Miteva K, Schultheiss HP, et al,. Mesenchymal stromal cells: A promising cell source for the treatment of inflammatory cardiomyopathy. Curr. Pharm. Des. 2011; 17 (30): 3295-307.
5. Ishikawa H, Jo JI, Tabata Y,. Liver anti-fibrosis therapy with mesenchymal stem cells secreting hepatocyte growth factor. J. Biomater. Sci. Polym. Ed. 2011.
6. Jungebluth P, Luedde M, Ferrer E, et al,. Mesenchymal stem cells restore lung function by recruiting resident and non-resident proteins. Cell Transplant. 2011; Mar 7. [Epub ahead of print].
7. Prata Kde L, Orellana MD, De Santis GC, et al,. Effects of high-dose chemotherapy on bone marrow multipotent mesenchymal stromal cells isolated from lymphoma patients. Exp. Hematol. 2010; 38 (4): 292-300.
8. Oliver JA, Maarouf O, Cheema FH, et al,. The renal papilla is a niche for adult kidney stem cells. J. Clin. Invest. 2004; 114: 795-804. (Pubitemid 39578738)
9. Alexandre CS, Volpini RA, Shimizu MH, et al,. Lineage-negative bone marrow cells protect against chronic renal failure. Stem Cells 2009; 27 (3): 682-92.
10. Striker GE,. The aging kidney phenotype and systemically derived stem cells. J. Am. Soc. Nephrol. 2011; 22 (11): 1958-60.
11. Zhen-Qiang F, Bing-Wei Y, Yong-Liang L, et al,. Localized expression of human BMP-7 by BM-MSCs enhances renal repair in an in vivo model of ischemia-reperfusion injury. Genes Cells. 2012; 17 (1): 53-64.
12. Morigi M, Imberti B, Zoja C, et al,. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J. Am. Soc. Nephrol. 2004; 15: 1794-804. (Pubitemid 38822058)
13. Herrera MB, Bussolati B, Bruno S, et al,. Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int. 2007; 72: 430-41. (Pubitemid 47237610)
14. Behr L, Hekmati M, Lucchini A, et al,. Evaluation of the effect of autologous mesenchymal stem cell injection in a large-animal model of bilateral kidney ischaemia reperfusion injury. K. Cell Prolif. 2009; 42 (3): 284-97.
15. Tögel F, Cohen A, Zhang P, et al,. Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. Stem Cells Dev. 2009; 18 (3): 475-85.
16. Tögel FE, Westenfelder C,. Mesenchymal stem cells: A new therapeutic tool for AKI. Nat. Rev. Nephrol. 2010; 6 (3): 179-83.
17. Perico N, Casiraghi F, Introna M, et al,. Autologous mesenchymal stromal cells and kidney transplantation: A pilot study of safety and clinical feasibility. Clin. J. Am. Soc. Nephrol. 2011; 6 (2): 412-22.
18. Ninichuk V, Gross O, Segerer S, et al,. Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int. 2006; 70: 121-9. (Pubitemid 44000128)
19. Lindoso RS, Araujo DS, AdÃo-Novaes J, et al,. Paracrine interaction between bone marrow-derived stem cells and renal epithelial cells. Cell Physiol. Biochem. 2011; 28 (2): 267-78.
20. Yeagy BA, Cherqui S,. Kidney repair and stem cells: A complex and controversial process. Pediatr. Nephrol. 2011; 26 (9): 1427-34.
21. Zarjou A, Kim J, Traylor AM, et al,. Paracrine effects of mesenchymal stem cells in cisplatin-induced renal injury require heme oxygenase-1. Am. J. Physiol. Renal Physiol. 2011; 300 (1): F254-62.
22. Chen J, Park HC, Addabbo F, et al,. Kidney-derived mesenchymal stem cells contribute to vasculogenesis, angiogenesis and endothelial repair. Kidney Int. 2008; 74 (7): 879-89.
23. Togel F, Weiss K, Yang Y, et al,. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am. J. Physiol. Renal Physiol. 2007; 292: F1626-F1635. (Pubitemid 46701891)
24. Bi B, Schmitt R, Israilova M, et al,. Stromal cells protect against acute tubular injury via an endocrine effect. J. Am. Soc. Nephrol. 2007; 18: 2486-96. (Pubitemid 47378865)
25. Imberti B, Morigi M, Tomasoni S, et al,. Insulin-like growth factor-1 sustains stem cell-mediated renal repair. J. Am. Soc. Nephrol. 2007; 18: 2921-8. (Pubitemid 350058399)
26. Tögel F, Zhang P, Hu Z, et al,. VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury. J. Cell. Mol. Med. 2009; 13: 2109-14.
27. Cantaluppi V, Biancone L, Romanazzi GM, et al,. Macrophage stimulating protein may promote tubular regeneration after acute injury. J. Am. Soc. Nephrol. 2008; 19: 1904-18.
28. Ratajczak J, Wysoczynski M, Hayek F, et al,. Membrane-derived microvesicles: Important and underappreciated mediators of cell-to-cell communication. Leukemia 2006; 20: 1487-95. (Pubitemid 44264090)
29. Ratajczak J, Miekus K, Kucia M, et al,. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: Evidence for horizontal transfer of mRNA and protein delivery. Leukemia 2006; 20: 847-56.
30. Deregibus MC, Cantaluppi V, Calogero R, et al,. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 2007; 110: 2440-8. (Pubitemid 47523165)
31. Chen Y, Qian H, Zhu W, et al,. Hepatocyte growth factor modification promotes the amelioration effects of human umbilical cord mesenchymal stem cells on rat acute kidney injury. Stem Cells Dev. 2011; 20 (1): 103-13.
32. Valadi H, Ekström K, Bossios A, et al,. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007; 9: 654-9. (Pubitemid 47214727)
33. Collino F, Deregibus MC, Bruno S, et al,. Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS ONE 2010; 5 (7): e11803.
34. Gatti S, Bruno S, Deregibus MC, et al,. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol. Dial. Transplant. 2011; 0: 1-10.
35. Bruno S, Grange C, Deregibus MC, et al,. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J. Am. Soc. Nephrol. 2009; 20: 1053-67.
36. Herrera MB, Fonsato V, Gatti S, et al,. Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J. Cell. Mol. Med. 2009; 14: 1605-18.
37. Yuan A, Farber EL, Rapoport AL, et al,. Transfer of microRNAs by embryonic stem cell microvesicles. PLoS ONE 2009; 4: e4722.
38. Pablo Bautista-GarcÄ A, Sanchez-Lozada LG, Cristobal-GarcÄa M, et al,. Chronic inhibition of NOS-2 ameliorates renal injury, as well as COX-2 and TGF-b1 overexpression in 5/6 nephrectomized rats. Nephrol. Dial. Transplant. 2006; 21: 3074-81.
39. Liu N, Tian J, Wang W, et al,. Effect and mechanism of erythropoietin on mesenchymal stem cell proliferation in vitro under the acute kidney injury microenvironment. Exp. Biol. Med. (Maywood) 2011; 236 (9): 1093-9.
40. Rombouts WJ, Ploemacher RE,. Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia 2003; 17: 160-70. (Pubitemid 36175902)
41. Peister A, Mellad JA, Larson BL, et al,. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation and differentiation potential. Blood 2004; 103: 1662-8. (Pubitemid 38268957)
42. Debeb BG, Zhang X, Krishnamurthy S, et al,. Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells. Mol. Cancer 2010; 9: 180-91.
43. Bi B, Guo J, Marlier A, et al,. Erythropoietin expands a stromal cell population that can mediate renoprotection. Am. J. Physiol. Renal Physiol. 2008; 295: F1017-F1022.
44. Sheng H, Hassanali S, Nugent C, et al,. Insulinoma-released exosomes or microparticles are immunostimulatory and can activate autoreactive T cells spontaneously developed in nonobese diabetic mice. J. Immunol. 2011; 187 (4): 1591-600.
45. Morel O, Toti F, Hugel B, et al,. Cellular microparticles: A disseminated storage pool of bioactive vascular effectors. Curr. Opin. Hematol. 2004; 11: 156-64. (Pubitemid 38952003)